Company survey response

Novartis

Member of UN Global Compact

Headquarters in Switzerland

Novartis website

🔎 Run a search for “Novartis”

Get RSS feed of these results

All stories

Story
17 April 2018
+ Deutsch - Hide

Am 2. April veröffentlichte die TagesWoche einen Artikel anlässlich der Beförderung von Novartis Ethik-Chefin Shannon Klinger in die Geschäftsleitung des Unternehmens. Der Artikel äußert zudem Bedenken über die Patentpolitik und Zugang zu Medikamenten,...

See full story

Story
17 April 2018

Novartis responds to concerns raised about the social & environmental impacts of its business practices

On 2 April, the German-Swiss newspaper TagesWoche published an article about Novartis' decision to name Shannon Klinger chief of ethics and compliance and elevate the function to be part of the executive board following concerns raised about its...

See full story

Company response
16 April 2018

Response by Novartis

Author: Novartis

At Novartis, corporate responsibility (CR) is central to how we run our business. Our CR strategy supports our company mission to discover new ways to improve and extend people’s lives and our vision to be a trusted leader in changing the practice of...

Read full response

Article
14 December 2017
+ Français - Hide

Author: Claude Béglé dans Le Temps (Suisse)

... Sur le fond, la cause qui sous-tend l’initiative «Multinationales responsables» est juste. En revanche... la formulation et les responsabilités méritent d’être précisées, sans quoi de sérieuses questions d’interprétation risquent de perturber l...

Read more

Article
4 December 2017
+ Français - Hide

Author: Matthieu Hoffstetter, Bilan (Suisse)

«Le respect des droits de l'homme devient un atout pour le business», 23 novembre 2017...

Read more

Article
9 July 2017

UK drugs groups seek court block on NHS price limits

Author: Sarah Neville, Financial Times (UK)

The UK drugs industry is going to court in an attempt to stop the country’s taxpayer-funded National Health Service from imposing new limits on the price it will pay for medicines. The action follows a government crackdown in April that limits funding...

Read more

Article
28 June 2017

John Ruggie analyses power of multinational firms - aims to bridge gap between voluntary & binding approaches

Author: John Ruggie, Harvard University, Regulation & Governance (Australia)

"Multinationals as global institution: Power, authority and relative autonomy", 27 June 2017...

Read more

Article
26 May 2017
+ Français - Hide

Author: Ram Etwareea, Le Temps (Suisse)

« Novartis attaque la Colombie en justice », 23 mai 2017...

Read more

Article
19 April 2017
+ Français - Hide

Author: Bilan (Suisse)

« Novartis accusé de pression sur la Colombie », 12 avril 2017...

Read more

Article
12 April 2017

Colombia: Leaked documents reveal Novartis threatened govt. with intl. investment arbitration over licensing of pharmaceutical patents

Author: Public Eye

"Compulsory licensing in Colombia: Leaked documents show aggressive lobbying by Novartis", 11 Apr 2017...

Read more